Paul Windisch
Overview
Explore the profile of Paul Windisch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Windisch P, Dennstadt F, Koechli C, Schroder C, Aebersold D, Forster R, et al.
Cureus
. 2025 Jan;
16(12):e75748.
PMID: 39811231
Introduction The application of natural language processing (NLP) for extracting data from biomedical research has gained momentum with the advent of large language models (LLMs). However, the effect of different...
2.
Windisch P, Dennstadt F, Koechli C, Forster R, Schroder C, Aebersold D, et al.
JCO Clin Cancer Inform
. 2024 Nov;
8:e2400150.
PMID: 39602661
Purpose: Extracting inclusion and exclusion criteria in a structured, automated fashion remains a challenge to developing better search functionalities or automating systematic reviews of randomized controlled trials in oncology. The...
3.
Foerster R, Zwahlen D, Schroeder C, Windisch P, Halatsch M, Alfieri A, et al.
Trials
. 2024 Nov;
25(1):762.
PMID: 39538259
Background: The SMILE study addresses a significant need in palliative oncology by evaluating the non-inferiority of a shortened, 3-fraction stereotactic body radiotherapy (SBRT) schedule against the traditional 5-fraction approach for...
4.
Windisch P, Dennstadt F, Koechli C, Forster R, Schroder C, Aebersold D, et al.
JAMIA Open
. 2024 Oct;
7(4):ooae116.
PMID: 39464799
Objectives: Extracting the sample size from randomized controlled trials (RCTs) remains a challenge to developing better search functionalities or automating systematic reviews. Most current approaches rely on the sample size...
5.
Schroder C, Tang H, Lenffer B, Buchali A, Zwahlen D, Forster R, et al.
Clin Transl Radiat Oncol
. 2024 Jul;
48:100806.
PMID: 39044780
Background: There is increasing data on re-irradiation to the prostate using stereotactic body radiotherapy (SBRT) after definitive radiotherapy for prostate cancer, with increasing evidence on prostate re-irradiation using a C-arm...
6.
Windisch P, Lutscher J, Forster R, Zwahlen D, Schroder C
J Clin Med
. 2024 Jun;
13(12).
PMID: 38930133
: Discontinuation of radiotherapy is rarely discussed in the scientific literature. The goal of this study was, therefore, to estimate the frequency of and reasons for treatment discontinuations in patients...
7.
Windisch P, Becker I, Tang H, Schroder C, Buchali A, Aebersold D, et al.
BMC Urol
. 2024 Feb;
24(1):28.
PMID: 38310268
Background: Prostate-related quality of life can be assessed with a variety of different questionnaires. The 50-item Expanded Prostate Cancer Index Composite (EPIC) and the International Prostate Symptom Score (IPSS) are...
8.
Scolari C, Buchali A, Franzen A, Forster R, Windisch P, Bodis S, et al.
Front Oncol
. 2023 Jul;
13:1175609.
PMID: 37456239
Purpose: Re-irradiation (re-RT) in head and neck cancer is challenging. This study prospectively explored the feasibility of re-RT in patients with loco-regionally recurrent or second primary head and neck cancer...
9.
Hanke L, Tang H, Schroder C, Windisch P, Kudura K, Shelan M, et al.
Cancers (Basel)
. 2023 Jul;
15(13).
PMID: 37444564
Introduction: Prostate bed radiotherapy (RT) is a major affecter of patients' long-term quality of life (QoL). To ensure the best possible outcome of these patients, dose constraints are key for...
10.
Koechli C, Zwahlen D, Schucht P, Windisch P
Eur J Radiol
. 2023 May;
164:110866.
PMID: 37207398
Purpose: Predicting the consistency of benign central nervous system (CNS) tumors prior to surgery helps to improve surgical outcomes. This review summarizes and analyzes the literature on using radiomics and/or...